1. Home
  2. ELVN vs KALU Comparison

ELVN vs KALU Comparison

Compare ELVN & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • KALU
  • Stock Information
  • Founded
  • ELVN 2016
  • KALU 1946
  • Country
  • ELVN United States
  • KALU United States
  • Employees
  • ELVN N/A
  • KALU N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • KALU Metal Fabrications
  • Sector
  • ELVN Health Care
  • KALU Industrials
  • Exchange
  • ELVN Nasdaq
  • KALU Nasdaq
  • Market Cap
  • ELVN 1.2B
  • KALU 1.2B
  • IPO Year
  • ELVN 2020
  • KALU 1991
  • Fundamental
  • Price
  • ELVN $20.73
  • KALU $85.64
  • Analyst Decision
  • ELVN Strong Buy
  • KALU Buy
  • Analyst Count
  • ELVN 5
  • KALU 3
  • Target Price
  • ELVN $41.20
  • KALU $69.00
  • AVG Volume (30 Days)
  • ELVN 747.2K
  • KALU 133.7K
  • Earning Date
  • ELVN 08-12-2025
  • KALU 07-23-2025
  • Dividend Yield
  • ELVN N/A
  • KALU 3.60%
  • EPS Growth
  • ELVN N/A
  • KALU 0.39
  • EPS
  • ELVN N/A
  • KALU 3.06
  • Revenue
  • ELVN N/A
  • KALU $3,063,900,000.00
  • Revenue This Year
  • ELVN N/A
  • KALU $11.04
  • Revenue Next Year
  • ELVN N/A
  • KALU $7.33
  • P/E Ratio
  • ELVN N/A
  • KALU $27.94
  • Revenue Growth
  • ELVN N/A
  • KALU 1.56
  • 52 Week Low
  • ELVN $13.30
  • KALU $46.81
  • 52 Week High
  • ELVN $30.03
  • KALU $100.07
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 52.08
  • KALU 74.89
  • Support Level
  • ELVN $19.22
  • KALU $79.44
  • Resistance Level
  • ELVN $21.90
  • KALU $81.90
  • Average True Range (ATR)
  • ELVN 1.49
  • KALU 2.37
  • MACD
  • ELVN -0.19
  • KALU 0.47
  • Stochastic Oscillator
  • ELVN 39.43
  • KALU 99.35

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

Share on Social Networks: